Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CMSA | ESNT |
|---|---|---|
| Price | $19.48 | $61.09 |
| Change today | ▲ 0.26% | ▲ 1.44% |
| Market cap | $5.49B | $5.49B |
| Return, 3 months | -6.1% | -5.0% |
| Return, year to date | -6.8% | -4.4% |
| Return, 1 year | -14.9% | +3.0% |
| P/E (TTM) | – | 8.5 |
| P/B | – | 1.0 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 2.16% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 49 | 34 |
| 30-day volatility | 10.9% | 29.8% |
| Max drawdown, 1 year | -17.7% | -16.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
